353 related articles for article (PubMed ID: 16403912)
1. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma.
Yang ZZ; Novak AJ; Stenson MJ; Witzig TE; Ansell SM
Blood; 2006 May; 107(9):3639-46. PubMed ID: 16403912
[TBL] [Abstract][Full Text] [Related]
2. CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Blood; 2007 Oct; 110(7):2537-44. PubMed ID: 17615291
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Cancer Res; 2006 Oct; 66(20):10145-52. PubMed ID: 17047079
[TBL] [Abstract][Full Text] [Related]
5. Determination of a CD4
Jafarinia M; Mehdipour F; Hosseini SV; Ghahramani L; Hosseinzadeh M; Ghaderi A
Tumour Biol; 2016 Nov; 37(11):14659-14666. PubMed ID: 27619682
[TBL] [Abstract][Full Text] [Related]
6. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
7. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells.
Hilchey SP; De A; Rimsza LM; Bankert RB; Bernstein SH
J Immunol; 2007 Apr; 178(7):4051-61. PubMed ID: 17371959
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.
Zhu S; Lin J; Qiao G; Xu Y; Zou H
Tumour Biol; 2015 Sep; 36(10):7907-13. PubMed ID: 25953262
[TBL] [Abstract][Full Text] [Related]
10. Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma.
Han Y; Wu J; Bi L; Xiong S; Gao S; Yin L; Jiang L; Chen C; Yu K; Zhang S
PLoS One; 2011; 6(12):e28649. PubMed ID: 22174855
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
12. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
Vahlenkamp TW; Tompkins MB; Tompkins WA
J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
[TBL] [Abstract][Full Text] [Related]
13. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
[TBL] [Abstract][Full Text] [Related]
14. Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.
Yang ZZ; Novak AJ; Ziesmer SC; Witzig TE; Ansell SM
Cancer Res; 2009 Jul; 69(13):5522-30. PubMed ID: 19509224
[TBL] [Abstract][Full Text] [Related]
15. LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.
Camisaschi C; Casati C; Rini F; Perego M; De Filippo A; Triebel F; Parmiani G; Belli F; Rivoltini L; Castelli C
J Immunol; 2010 Jun; 184(11):6545-51. PubMed ID: 20421648
[TBL] [Abstract][Full Text] [Related]
16. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
[TBL] [Abstract][Full Text] [Related]
17. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
18. Detection of T-regulatory cells has a potential role in the diagnosis of classical Hodgkin lymphoma.
Bosler DS; Douglas-Nikitin VK; Harris VN; Smith MD
Cytometry B Clin Cytom; 2008 Jul; 74(4):227-35. PubMed ID: 18271019
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
20. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
